Drugmaker Pfizer posts 19 pct drop in 3Q profit due to generic competition, higher costs

Pfizer Inc. says third-quarter profit dropped 19 per cent as generic competition continued to cut sales, while operational expenses, taxes and charges all rose.

The maker of Lyrica for fibromyalgia says net income was $2.59 billion, or 39 cents per share, down from $3.21 billion, or 43 cents per share, a year earlier.

Excluding one-time items, the world’s second-largest drugmaker says net income would have been $3.86 billion, or 58 cents per share. Analysts surveyed by FactSet expected 56 cents per share.

Revenue totalled $12.64 billion, down 2 per cent from $12.95 billion a year ago. Analysts expected $12.69 billion.

New York-based Pfizer raised the lower end of its 2013 profit forecast by a nickel and now expects $2.15 to $2.20 per share.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.